Results for "consumer data right"
221-230 of 563 results for 'consumer data right'
The AI-generated picture becomes clearer: key legal considerations emerging for generative AI developers and their customers
With rapid developments, it is proving increasingly difficult to stay across the full range of implications for the use and regulation of generative AI tools. This Insight is intended to provide an update on the developments in generative. ...
ESG contract clauses — drafting tips to reduce your exposure to disputes and complaints
Interest in environmental, social and governance (ESG) is continuing to grow at a rapid pace, including ESG-related goods and services. ...
Using gen AI tools for business? Be aware of the (many) limitations on your IP protections
To assist businesses to make informed decisions about which AI tools to use and for what purposes, we have conducted an in-depth analysis of the terms and conditions applicable to a range of commonly used, off-the-shelf generative AI tools from an intellectual property perspective. ...
Optus class action privilege claims rejected
The Full Federal Court has refused Optus' appeal from a Federal Court decision rejecting its legal privilege claim over a factual investigation report commissioned in response to a data breach, on the basis that Optus had not established that the report was prepared for the dominant purpose of legal ...
Privacy disclosure incident leads to largest ever award of compensation for non-economic loss.
The determination issued by the OAIC for breaches of the Privacy Act by the Department of Home Affairs confirms that compensation can be ordered to be paid for non-economic losses related to data breaches. ...
Repurposing existing medicines – industry to have its say in reshaping Australia's regulatory future
The Therapeutics Goods Administration (the TGA) is consulting with the public and industry to potentially reform regulatory and reimbursement frameworks, to incentivise the repurposing of existing medicines. Off-label use (where a medicine is used for a disease or medical condition for which it does ...
Preparing for voluntary standards and mandatory legislation: a deep dive into Australia's evolving AI regulatory landscape
Over the past few weeks, the Australian Government has published a series of standards, proposals and policies which foreshadow the principles likely to be adopted in mandatory AI legislation once introduced. ...
From CAD to courtroom: how using the wrong drawing can cost you
A recent Federal Court decision has pulled the intersection between copyright and design law into the spotlight, with important implications for businesses relying on drawings in product development. ...
AI Governance Toolkit for General Counsel and Boards
We believe companies need to start applying guardrails to AI development, use and deployment, but we understand that it can be hard to know where and how to start. That's why we've developed an AI Governance Toolkit for General Counsel and Boards, to help companies manage their AI risk. ...
Guide to addressing ESG impacts in generative AI deployment
This guide outlines key ESG risks and impacts companies deploying AI should consider, the questions they should be asking, and what to do in response. ...